Akarawin Sirimongkol

Dr. Akarawin Sirimongkol


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
AMAsada Methasate
Asada Methasate
ASAkarawin Sirimongkol
Akarawin Sirimongkol
CNChawisa Nampoolsuksan
Chawisa Nampoolsuksan
JSJirawat Swangsri
Jirawat Swangsri
TPThammawat Parakonthun
Thammawat Parakonthun
Background/Objectives: To identify independent predictors of free peritoneal cancer cells (FPCC), and to investigate survival outcomes relative to peritoneal cytology status among patients underwent intended curative gastrectomy for adenocarcinoma of stomach or esophagogastric junction. Methods: Medical record of patients underwent radical surgery during January 2005-December 2020 were retrospectively reviewed. Clinical data and cytology results were evaluated. Multivariate Cox regression analysis was used to identify independent predictors of FPCC. Kaplan-Meier survival analysis was used to estimate disease recurrence and survival outcomes. Results: Of the 349 enrolled patients, 188 (53.8%) had negative cytology, 32 (9.2%) had positive cytology, and 129 (36.9%) had atypical cells in peritoneal cytology. Multivariate analysis revealed poor differentiation (adjusted odds ratio [aOR]: 2.63, 95% confidence interval [95%CI]: 1.04-6.82; p=0.015), pT4 (aOR: 4.62, 95%CI: 1.28-14.34; p=0.018), pN3 (aOR: 4.13, 95%CI: 1.14-15.03; p=0.031), and metastatic lymph node ratio >0.40 (aOR: 6.49, 95%CI: 1.44-29.14; p=0.015) as independent predictors of FPCC. Median survival duration of patients with negative, positive, and atypical cell cytology was 34.1, 13.1, and 28.7 months, respectively (p<0.001). 5-year OS was 27.2%, 8.3%, and 25.3%, respectively (p<0.001). 3-year DFS was 17.8%, 0.0%, and 17.4%, respectively (p<0.001). Median time to disease recurrence was 20.5, 4.9, and 11.3 months, respectively (p0.40 are independent predictors of FPCC. The presence of FPCC was significantly associated with poor survival and disease recurrence outcomes.

10 November 2025 in Surgeries
Verified
Journal Article
Open access
PDF file
AMAsada Methasate
Asada Methasate
ASAkarawin Sirimongkol
Akarawin Sirimongkol
CNChawisa Nampoolsuksan
Chawisa Nampoolsuksan
JSJirawat Swangsri
Jirawat Swangsri
TPThammawat Parakonthun
Thammawat Parakonthun
Background/Objectives: To identify independent predictors of free peritoneal cancer cells (FPCC), and to investigate survival outcomes relative to peritoneal cytology status among patients who underwent intended curative gastrectomy for adenocarcinoma of the stomach or esophagogastric junction. Methods: Medical records of patients who underwent radical surgery between January 2005 and December 2020 were retrospectively reviewed. Clinical data and cytology results were evaluated. Multivariate Cox regression analysis was used to identify independent predictors of FPCC. Kaplan–Meier survival analysis was used to estimate disease recurrence and survival outcomes. Results: Out of the 349 enrolled patients, 188 (53.8%) had negative cytology, 32 (9.2%) were positive, and 129 (36.9%) showed atypical cells in peritoneal cytology. Poor differentiation (adjusted odds ratio [aOR]: 2.63, 95% confidence interval [95%CI]: 1.04–6.82; p = 0.015), pT4 (aOR: 4.62, 95%CI: 1.28–14.34; p = 0.018), pN3 (aOR: 4.13, 95%CI: 1.14–15.03; p = 0.031), and metastatic lymph node ratio >0.40 (aOR: 6.49, 95%CI: 1.44–29.14; p = 0.015) were independent predictors of FPCC. Median overall survival was 34.1 months in the negative group, 13.1 months in the positive group, and 28.7 months in the atypical cell group (p < 0.001). Median time to disease recurrence was 20.5, 4.9, and 11.3 months, respectively (p < 0.001). Survival and recurrence outcomes in the atypical cell group were comparable to those with negative cytology. Conclusions: Poorly differentiated histology, pT4, pN3, and metastatic lymph node ratio >0.40 are independent predictors of FPCC, which is significantly associated with poor survival and disease recurrence outcomes. These findings suggest that high-risk patients may benefit from routine peritoneal cytologic screening during surgery to improve risk stratification and guide postoperative treatment planning.